Roland Schnell

1.9k total citations
30 papers, 1.2k citations indexed

About

Roland Schnell is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Roland Schnell has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 13 papers in Immunology and 12 papers in Oncology. Recurrent topics in Roland Schnell's work include Lymphoma Diagnosis and Treatment (13 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Toxin Mechanisms and Immunotoxins (9 papers). Roland Schnell is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Toxin Mechanisms and Immunotoxins (9 papers). Roland Schnell collaborates with scholars based in Germany, United States and Switzerland. Roland Schnell's co-authors include Andreas Engert, Peter Borchmann, Volker Diehl, Hinrich P. Hansen, Marcel Reiser, H. Schulz, Stefan Barth, Michael Hallek, Victor Gheţie and Franck Morschhauser and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cochrane Database of Systematic Reviews.

In The Last Decade

Roland Schnell

30 papers receiving 1.2k citations

Peers

Countries citing papers authored by Roland Schnell

Since Specialization

Citations

This map shows the geographic impact of Roland Schnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Schnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Schnell more than expected).

Fields of papers citing papers by Roland Schnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Schnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Schnell. The network helps show where Roland Schnell may publish in the future.

Co-authorship network of co-authors of Roland Schnell

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Schnell. A scholar is included among the top collaborators of Roland Schnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Schnell. Roland Schnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study 2022 ·Journal of bone oncology ·Andreas Jakob, (unknown), Arnd Nusch, (unknown), Roland Schnell, (unknown), (unknown), (unknown), Christoph Losem, Manfred Welslau, (unknown), Karin Potthoff	7
2	Rare lymphomas in routine practice – Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms 2021 ·Hematological Oncology ·Wolfgang Knauf, Wolfgang Abenhardt, Michael Koenigsmann, Christoph Maintz, (unknown), (unknown), Roland Schnell, (unknown), (unknown), (unknown), Norbert Marschner, (unknown)	3
3	Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement 2020 ·BMC Immunology ·Rudolf Weide, Roland Schnell, (unknown), Michael Koenigsmann, Burkhard Otremba, (unknown), Jan Wierecky, (unknown), Manfred Hensel, Martine Klausmann, (unknown), (unknown), (unknown)	3
4	Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer – final results from the prospective German TLK cohort study 2017 ·Lung Cancer ·(unknown), Roland Schnell, (unknown), (unknown), (unknown), (unknown), Martina Jänicke, Norbert Marschner	21
5	Relapsed Hodgkin Lymphoma in Older Patients: A Comprehensive Analysis From the German Hodgkin Study Group 2013 ·Journal of Clinical Oncology ·Boris Böll, Helen Goergen, (unknown), Julia Meißner, Stefan W. Krause, Roland Schnell, Bastian von Tresckow, Dennis A. Eichenauer, Stephanie Sasse, Michael Fuchs, Karolin Behringer, Beate Klimm, Ralph Naumann, Volker Diehl, Andreas Engert, Peter Borchmann	35
6	Yttrium-90 Ibritumomab Tiuxetan-Induced Complete Remission in a Patient with Classical Lymphocyte-Rich Hodgkin’s Lymphoma 2008 ·Onkologie ·Roland Schnell, Markus Dietlein, Klaus Schomäcker, Carsten Kobe, Peter Borchmann, H Schicha, Michael Hallek, Andreas Engert	10
7	SGN-30 (Seattle genetics). 2006 ·PubMed ·Roland Schnell, Peter Borchmann	12
8	Imaging of central nervous system lymphomas with iodine‐123 labeled rituximab 2005 ·European Journal Of Haematology ·Markus Dietlein, Hendrik Pels, H. Schulz, Oliver Staak, Peter Borchmann, Klaus Schomäcker, Thomas Fischer, W. Eschner, Elke Pogge von Strandmann, H Schicha, Andreas Engert, Roland Schnell	29
9	Current treatment and immunotherapy of Hodgkin's lymphoma. 2005 ·PubMed ·Beate Klimm, Roland Schnell, Volker Diehl, Andreas Engert	27
10	The role of pixantrone in the treatment of non-Hodgkin’s lymphoma 2005 ·Expert Opinion on Investigational Drugs ·Peter Borchmann, Roland Schnell	4
11	Metalloproteinase inhibition augments antitumor efficacy of the anti‐CD30 immunotoxin Ki‐3(scFv)‐ETA′ against human lymphomas in vivo 2004 ·International Journal of Cancer ·(unknown), Peter Borchmann, Roland Schnell, Samir Tawadros, Hans Lange, Michael Hühn, Alexander Klimka, Mehmet Kemal Tur, Stefan Barth, Andreas Engert, Hinrich P. Hansen	16
12	Monoclonal antibody-based immunotherapy of Hodgkin's lymphoma. 2004 ·PubMed ·Peter Borchmann, Roland Schnell, H. Schulz, Andreas Engert	4
13	The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma 2003 ·Blood ·Peter Borchmann, Jack Treml, Hinrich P. Hansen, Claudia Gottstein, Roland Schnell, Oliver Staak, Huifen Zhang, Thomas Davis, Tibor Keler, Volker Diehl, Robert F. Graziano, Andreas Engert	78
14	A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma. 2002 ·PubMed ·Roland Schnell, Oliver Staak, Peter Borchmann, Christine Schwartz, (unknown), Hinrich P. Hansen, John Schindler, Victor Gheţie, Ellen S. Vitetta, Volker Diehl, Andreas Engert	112
15	Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma 2002 ·Blood ·Peter Borchmann, Roland Schnell, (unknown), Oliver Manzke, Thomas Davis, Lionel D. Lewis, Detlev Behnke, Claudia Wickenhauser, Petra Schiller, Volker Diehl, Andreas Engert	71
16	Recombinant anti-CD25 immunotoxin RFT5(SCFV)-ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID mice 2000 ·International Journal of Cancer ·Stefan Barth, Michael Hühn, B. Matthey, Roland Schnell, Samir Tawadros, (unknown), Johann Lorenzen, Volker Diehl, Andreas Engert	24
17	Ki-4(scFv)–ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice 2000 ·Blood ·Stefan Barth, Michael Hühn, (unknown), Samir Tawadros, Roland Schnell, Timo Schinköthe, Volker Diehl, Andreas Engert	13
18	9 Future treatment strategies: fact or fiction? 1996 ·Baillière s Clinical Haematology ·Roland Schnell, Stefan Barth, Volker Diehl, Andreas Engert	5
19	Cocktails of ricin a‐chain immunotoxins against different antigens on hodgkin and sternberg‐reed cells have superior anti‐tumor effects against H‐RS cells in vitro and solid Hodgkin tumors in mice 1995 ·International Journal of Cancer ·Andreas Engert, Claudia Gottstein, Heribert Bohlen, U. Winkler, Gisela Schön, (unknown), Roland Schnell, Volker Diehl, Philip E. Thorpe	27
20	The in vivo anti-tumor activity of immunotoxins containing two versus one deglycosylated ricin A chains 1995 ·Cancer Letters ·Victor Gheţie, Andreas Engert, Roland Schnell, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact